Abstract:Cancer is a leading cause of death in many countries around the world. However, the efficacy of current treatments available for variety of cancers is considered to be suboptimal due to the pathophysiological challenges associated with the disease which limits the efficacy of the anticancer drugs. Moreover, the vulnerability towards off-target effects and high toxicity also limits the use of drugs for the treatment of cancers. Besides, the biopharmaceutical challenges like poor water solubility and permeability of the drugs, along with the absence of active targeting capability further decreases the utility of drugs in cancer therapy. As a result of these deficiencies, the current therapeutic strategies face noncompliance to patients for providing meaningful benefits after administration. With the advancements in nanotechnology, there has been a paradigm shift in the modalities for cancer treatment with the help of phytomedicine-based nanosized drug delivery systems coupled with variegated surface-engineering strategies for targeted drug delivery. Among these delivery systems, lipid-based nanoparticles are considered as one of the highly biocompatible, efficient and effective systems extensively explored for anticancer drug delivery. These include diverse range of systems including liposomes, nanoemulsions, solid lipid nanoparticles, nanostructured lipidic carriers and supramolecular carriers, which alters pharmacokinetic and biodistribution of the drugs for active targeting to the desired site of action by overcoming the biopharmaceutical challenges associated with anticancer drug delivery. The present review endeavours to provide a comprehensive account on the recent advances in the application of lipid-based nanostructured systems for improving the pharmacotherapeutic performance of phytomedicines for cancer targeting application.

Advances in Lipid-Based Nanocarriers for Breast Cancer Metastasis Treatment

Smart Nanoparticles for Breast Cancer Treatment Based on the Tumor Microenvironment

Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy

Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review

Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses

Recent Advances in Liposome Formulations for Breast Cancer Therapeutics.

Cancer Chemotherapy with Lipid-Based Nanocarriers

Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatment

Cell- and Subcellular Organelle-Targeting Nanoparticle-Mediated Breast Cancer Therapy

Advancements in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Breast Cancer Therapy

Nano-drug delivery system: a promising approach against breast cancer

Nano-Based Drug Delivery System in Breast Cancer Treatment

Advances in anti-breast cancer drugs and the application of nano-drug delivery systems in breast cancer therapy

Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting

Lipid nanoparticles-based RNA therapies for breast cancer treatment

Lipid Nanoparticles-Based Therapy in Liver Metastasis Management: from Tumor Cell-Directed Strategy to Liver Microenvironment-Directed Strategy

Targeted Drug Delivery with Lipid-based Nanoparticles: Innovations for Improved Cancer Therapy

Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers

Recent advances and clinical translation of liposomal delivery systems in cancer therapy

Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies